The worst newsletter to date. Their language were very euphoric and exaggerating. They avoided explicitly answering the main points we all wanted.
1. Is the IDMC review of the phase 2 Her-Vaxx interim data being delayed by Covid? Surely they could have talked with the IDMC and relayed that.
2. Will Covid delay the pd1 and CF33 phase 1 trial commencement dates?
Believe us, believe us, believe us is all they are saying. No substance. Nothing new. They brushed over this pandemic without specifics.
Now all you lot can start bashing me for offering an alternative view. Cheers.
April Newsletter now out, page-17
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.002(3.85%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $332.9K | 6.302M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 539790 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1243558 | 12 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |